QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
NASDAQ:CUTR

Cutera (CUTR) Stock Forecast, Price & News

$5.90
-0.23 (-3.75%)
(As of 12:57 PM ET)
Compare
Today's Range
$5.88
▼
$6.29
50-Day Range
$6.13
▼
$20.05
52-Week Range
$5.88
▼
$52.89
Volume
185,438 shs
Average Volume
753,857 shs
Market Capitalization
$117.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.20
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Cutera MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
394.9% Upside
$29.20 Price Target
Short Interest
Healthy
26.18% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Cutera in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$346,300 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($4.35) to ($2.46) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Computer And Technology Sector

449th out of 599 stocks

Electromedical Equipment Industry

18th out of 21 stocks

See Top Rated MarketRank™ Stocks Here

CUTR stock logo

About Cutera (NASDAQ:CUTR) Stock

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

CUTR Price History

CUTR Stock News Headlines

September 23, 2023 | americanbankingnews.com
Cutera, Inc. (NASDAQ:CUTR) Receives Consensus Rating of "Hold" from Analysts
September 21, 2023 | americanbankingnews.com
Cutera, Inc. (NASDAQ:CUTR) Receives $29.20 Consensus PT from Brokerages
September 29, 2023 | PressReach (Ad)
This Stock's a Sleeping Giant
The stock everyone has their eye on - discover why it's the talk of the investment world.
September 7, 2023 | finance.yahoo.com
Cutera Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO®
September 1, 2023 | finance.yahoo.com
Cutera Reports Inducement Grants as permitted by the Nasdaq Listing Rules
September 1, 2023 | finance.yahoo.com
Taylor Harris Bought 12% More Shares In Cutera
September 1, 2023 | businesswire.com
CUTERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cutera, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 24, 2023 | markets.businessinsider.com
Cutera Names Jeff Jones COO
September 29, 2023 | PressReach (Ad)
This Stock's a Sleeping Giant
The stock everyone has their eye on - discover why it's the talk of the investment world.
August 24, 2023 | msn.com
Cutera gets new operations chief
August 24, 2023 | finance.yahoo.com
Cutera, Inc. Appoints Jeff Jones as Chief Operating Officer
August 11, 2023 | finance.yahoo.com
Cutera, Inc. (NASDAQ:CUTR) Analysts Are Reducing Their Forecasts For This Year
August 8, 2023 | finance.yahoo.com
Cutera (CUTR) Reports Q2 Loss, Misses Revenue Estimates
August 1, 2023 | finance.yahoo.com
Pura Vida Investments, LLC Acquires Additional Shares in Cutera Inc
July 27, 2023 | msn.com
Cutera names Taylor Harris CEO
July 27, 2023 | reuters.com
Cutera taps serial dealmaker Harris as CEO, stock price surges
July 27, 2023 | msn.com
Piper Sandler Upgrades Cutera (CUTR)
July 27, 2023 | bizjournals.com
After board upheaval, Peninsula aesthetics company taps CEO with deep deal history
July 21, 2023 | finance.yahoo.com
Cutera, Inc. to Announce Second Quarter Results on August 8, 2023
July 21, 2023 | businesswire.com
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cutera, Inc. (CUTR)
July 15, 2023 | prnewswire.com
CUTERA SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cutera, Inc. - CUTR
July 8, 2023 | nasdaq.com
Stifel Maintains Cutera (CUTR) Buy Recommendation
July 8, 2023 | prnewswire.com
CUTERA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cutera, Inc. - CUTR
July 1, 2023 | stockhouse.com
JULY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Cutera, Inc. with Losses of $100,000 to Contact the Firm
June 26, 2023 | benzinga.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cutera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CUTR
June 21, 2023 | benzinga.com
Cutera, Inc. (CUTR) Equity Alert: Contact Robbins LLP for Information About Class Action Against Cutera, Inc. and Lead Plaintiff Deadline
June 16, 2023 | benzinga.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Cutera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CUTR
See More Headlines
Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Company Calendar

Last Earnings
8/08/2023
Today
9/29/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
NASDAQ:CUTR
CUSIP
N/A
CIK
1162461
Web
www.cutera.com
Phone
(415) 657-5500
Fax
415-330-2444
Employees
540
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$29.20
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$18.00
Forecasted Upside/Downside
+376.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($3.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-82,340,000.00
Net Margins
-31.08%
Pretax Margin
-30.19%
Return on Equity
-489.05%
Return on Assets
-16.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.59
Quick Ratio
2.92

Sales & Book Value

Annual Sales
$252.40 million
Price / Sales
0.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.77) per share
Price / Book
-7.96

Miscellaneous

Outstanding Shares
19,940,000
Free Float
19,525,000
Market Cap
$122.23 million
Optionable
Optionable
Beta
1.65

Social Links

12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Michael A. Karavitis Ph.D. (Age 53)
    Exec. VP & Chief Technology Officer
    Comp: $595.8k
  • Mr. Taylor C. Harris (Age 47)
    Pres, CEO & Director
  • Mr. Stuart Drummond
    Interim Chief Financial Officer
  • Mr. Jeffrey S. Jones (Age 67)
    Chief Operating Officer
  • Mr. Charles G. Thier (Age 60)
    Chief Information Officer
  • Anne Werdan
    Director of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CUTR Stock - Frequently Asked Questions

Should I buy or sell Cutera stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CUTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CUTR, but not buy additional shares or sell existing shares.
View CUTR analyst ratings or view top-rated stocks.

What is Cutera's stock price forecast for 2023?

5 equities research analysts have issued 12 month price objectives for Cutera's stock. Their CUTR share price forecasts range from $18.00 to $50.00. On average, they predict the company's share price to reach $29.20 in the next twelve months. This suggests a possible upside of 376.3% from the stock's current price.
View analysts price targets for CUTR or view top-rated stocks among Wall Street analysts.

How have CUTR shares performed in 2023?

Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR stock has decreased by 86.1% and is now trading at $6.13.
View the best growth stocks for 2023 here.

Are investors shorting Cutera?

Cutera saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 5,220,000 shares, a decrease of 8.7% from the August 31st total of 5,720,000 shares. Based on an average daily trading volume, of 756,500 shares, the short-interest ratio is presently 6.9 days.
View Cutera's Short Interest.

When is Cutera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our CUTR earnings forecast.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) issued its quarterly earnings results on Tuesday, August, 8th. The medical device company reported ($1.59) EPS for the quarter, missing the consensus estimate of ($0.55) by $1.04. The medical device company earned $61.20 million during the quarter, compared to analysts' expectations of $64.93 million. Cutera had a negative net margin of 31.08% and a negative trailing twelve-month return on equity of 489.05%. The firm's quarterly revenue was down 4.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($2.53) earnings per share.

What ETF holds Cutera's stock ?

SPDR S&P Health Care Equipment ETF holds 517,362 shares of CUTR stock, representing 1.65% of its portfolio.

What guidance has Cutera issued on next quarter's earnings?

Cutera updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $220.00 million-$230.00 million, compared to the consensus revenue estimate of $264.05 million.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

How do I buy shares of Cutera?

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $6.13.

How much money does Cutera make?

Cutera (NASDAQ:CUTR) has a market capitalization of $122.23 million and generates $252.40 million in revenue each year. The medical device company earns $-82,340,000.00 in net income (profit) each year or ($3.87) on an earnings per share basis.

How many employees does Cutera have?

The company employs 540 workers across the globe.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.

This page (NASDAQ:CUTR) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -